Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

721
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
721
Selectins01:25

Selectins

3.3K
Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Select animal models of colitis and their value in predicting clinical efficacy of biological therapies in ulcerative colitis.

Expert opinion on drug discovery·2020
See all related articles

Related Experiment Video

Updated: Jun 29, 2025

Integrate Imaging Flow Cytometry and Transcriptomic Profiling to Evaluate Altered Endocytic CD1d Trafficking
09:01

Integrate Imaging Flow Cytometry and Transcriptomic Profiling to Evaluate Altered Endocytic CD1d Trafficking

Published on: October 29, 2018

6.8K

The Opposite Functions of CD30 Ligand Isoforms.

Ignat Printsev1, Elyas Alalli1, Janine Bilsborough1

  • 1F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Current Issues in Molecular Biology
|March 27, 2024
PubMed
Summary

A newly discovered second isoform of CD30 ligand (TNFSF8) does not promote inflammation. This isoform can inhibit the canonical CD30 ligand

Keywords:
CD30CD30 ligandcell signalinginflammatory bowel diseaseprotein isoforms

More Related Videos

Author Spotlight: Streamlining PCR Methods for Enhanced Accessibility and Efficiency
05:30

Author Spotlight: Streamlining PCR Methods for Enhanced Accessibility and Efficiency

Published on: March 1, 2024

486
A Method For Production of Recombinant mCD1d Protein in Insect Cells.
09:41

A Method For Production of Recombinant mCD1d Protein in Insect Cells.

Published on: December 10, 2007

10.8K

Related Experiment Videos

Last Updated: Jun 29, 2025

Integrate Imaging Flow Cytometry and Transcriptomic Profiling to Evaluate Altered Endocytic CD1d Trafficking
09:01

Integrate Imaging Flow Cytometry and Transcriptomic Profiling to Evaluate Altered Endocytic CD1d Trafficking

Published on: October 29, 2018

6.8K
Author Spotlight: Streamlining PCR Methods for Enhanced Accessibility and Efficiency
05:30

Author Spotlight: Streamlining PCR Methods for Enhanced Accessibility and Efficiency

Published on: March 1, 2024

486
A Method For Production of Recombinant mCD1d Protein in Insect Cells.
09:41

A Method For Production of Recombinant mCD1d Protein in Insect Cells.

Published on: December 10, 2007

10.8K

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Tumor necrosis factor superfamily member 8 (TNFSF8), or CD30 ligand, is expressed on immune cells and signals via the CD30 receptor.
  • CD30/CD30 ligand signaling influences immune cell differentiation, survival, and cytokine production, and is implicated in malignancies and inflammatory diseases.
  • A CD30 antibody therapy is approved for lymphomas, but only the canonical CD30 ligand isoform has been studied.

Purpose of the Study:

  • To investigate the properties and signaling functions of the second, previously undescribed, CD30 ligand isoform.
  • To determine if the second CD30 ligand isoform possesses pro-inflammatory activity.
  • To understand the interaction between the two CD30 ligand isoforms and their impact on CD30 receptor signaling.

Main Methods:

  • Analysis of mRNA expression of both CD30 ligand isoforms in peripheral blood mononuclear cells (PBMCs) from healthy donors.
  • Cell biology and biochemistry techniques to assess the functional properties of the second CD30 ligand isoform.

Main Results:

  • Both canonical and second isoforms of CD30 ligand mRNA were detected in PBMCs from all tested healthy donors.
  • The second CD30 ligand isoform exhibits no discernible pro-inflammatory function.
  • The second isoform acts as a negative regulator, restricting canonical CD30 ligand signaling by preventing receptor interaction.

Conclusions:

  • The second CD30 ligand isoform has distinct functional properties compared to the canonical isoform.
  • This isoform's inhibitory role suggests it could be a target for modulating CD30-mediated immune responses.
  • Findings have implications for developing novel therapeutics targeting the CD30/CD30 ligand pathway in cancer and inflammatory conditions.